Impact of combined oral contraceptives and spironolactone on hirsutism and quality of life
Combined oral contraceptives (COC) and spironolactone are the first and second-line treatment of mild hirsutism, since the use of cyproterone acetate was restricted to the treatment of severe hirsutism by the french guidelines for hyperandrogenism published in May 2020. Because spironolactone was un...
Gespeichert in:
Veröffentlicht in: | Gynécologie, obstétrique, fertilité & sénologie obstétrique, fertilité & sénologie, 2022-09, Vol.50 (9), p.591-599 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng ; fre |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!